Sebacia is a clinical-stage medical device company dedicated to creating new light-based therapies for the treatment of dermatological conditionsy. The Company seeks to provide an alternative to the topical and systemic drugs currently available for the treatment of acne. SEBACIA leveraged the potential of gold microparticles — long-studied in several areas of medical research, including tumor ablation — and laser energy to formulate a topical solution for acne. The intention was to develop a system that could deliver particles into the gland that could be calibrated to absorb wavelengths of laser light and avoid absorption into the skin. Thus, it would selectively heat only the targeted skin structures that are involved in acne.